Related Experiment Video
Updated: May 3, 2026

A Novel Surgical Technique in a Sheep Model for Suburethral Graft Implantation
Published on: June 20, 2025
Endoscopic correction of complex cases of vesicoureteral reflux utilizing Vantris as a new non-biodegradable
Boris Chertin1, Wael Abu Arafeh, Stanislav Kocherov
1Department of Pediatric Urology, Shaare Zedek Medical Center, Faculty of Medical Science, Hebrew University, P.O.B 3235, 91031, Jerusalem, Israel, boris.chertin@gmail.com.
Insights
Vantris injection effectively treated complex vesicoureteral reflux (VUR) in children, achieving high success rates and normal kidney appearance post-procedure. This new non-biodegradable substance shows promise for VUR resolution.
Area of Science:
- Pediatric Urology
- Minimally Invasive Surgery
- Biomaterials
Background:
- Vesicoureteral reflux (VUR) in children, especially complex cases, presents significant management challenges.
- Endoscopic correction is a common treatment modality, but efficacy in intricate VUR anatomies requires evaluation.
- Novel tissue-augmenting substances are needed to improve outcomes in challenging VUR cases.
Purpose of the Study:
- To prospectively assess the efficacy of Vantris, a new non-biodegradable tissue-augmenting substance, for endoscopic correction of complex VUR in pediatric patients.
- To evaluate the success rate and safety profile of Vantris in a cohort of children with diverse and complicated VUR presentations.
Main Methods:
- A prospective study involving 37 children with complex VUR undergoing endoscopic correction with Vantris over four years.
- Treatment encompassed various complex VUR etiologies including persistent reflux, duplication, diverticulum, poorly functioning kidneys, ureterocele, stump reflux, prune belly syndrome, and urogenital sinus.
- VUR grading ranged from Grade I to V, with a total of 38 renal refluxing units treated.
Main Results:
- Successful reflux correction was achieved in 89.4% of renal refluxing units (RRU) after a single Vantris injection and in an additional 5.3% after a second injection.
- No VUR recurrence was observed during follow-up.
- Voiding cystourethrogram (VCUG) and ultrasound (US) demonstrated successful outcomes, with US showing normal kidney appearance in all patients.
Conclusions:
- Vantris injection demonstrates a high success rate for reflux resolution in complex pediatric VUR cases.
- The non-biodegradable nature of Vantris appears to provide durable correction.
- Vantris represents a promising new option for managing challenging VUR anatomies in children.
Purpose:
We aimed to evaluate prospectively the efficacy of Vantris as a new non-biodegradable tissue-augmenting substance in children with complex cases of VUR.
Materials And Methods:
Over the last 4 years, 37 children (28 female and 9 male) with a mean age of 5.8 ± 3.1 years (mean ± SD) underwent endoscopic correction of complex VUR. A total of 38 renal refluxing units (RRU) was treated as 5 had persistent reflux after open surgery, 16 had duplication, 4 had Hutch diverticulum, 6 had small poorly functioning kidneys (less than 20% of relative renal function) with grade V VUR, 2 had ureterocele after puncture, 3 had persistent stump reflux, 1 had prune belly syndrome, and 1 had urogenital sinus. VUR was Grade I in 2, Grade II in 9, Grade III in 11, Grade IV in 10, and Grade V in 6 RRU, respectively.
Results:
The reflux was corrected in 34 (89.4%) RRU after a single injection, after second injection in 2 (5.3%) RRU. In 2 (5.3%) RRU, VUR downgraded to Grade I (1RRU) and Grade II (1RRU) and they were taken off antibiotic prophylaxis. VCUG was performed in 11 (73.3%) of 15 children who completed 1 year and in 3 (33.3%) of 9 who completed 3 years of follow up as a part of the routine protocol. None showed VUR recurrence. US demonstrated normal appearance of kidneys in all patients.
Conclusion:
Our data show that Vantris injection provides a high level of reflux resolution in complex cases of VUR.
Related Concept Videos
Urinary Tract Calculi VI: Surgical Management
Urinary Tract Calculi III: Medical Management

